GENELUX Corp

GNLX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001231457

SEC filings (opens in a new tab)

In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding GENELUX Corp changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of GNLX: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Q2 2026	Change
Holders	71	72	+1
Shares	9.30M	9.81M	+508.5K (+5.5%)
Value	$23.3M	$29.5M	+$6.15M (+26.4%)

New holders (11)

Institutions that held GENELUX Corp at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to GNLX in Q2 2026
Institution	Shares	Value	% of portfolio
Global Retirement Partners, LLC	227,854	$685.8K	0.01%
Citadel Advisors LLC	85,481	$257.3K	0.00%
Quadrature Capital Ltd	45,881	$138.1K	0.00%
Marshall Wace, LLP	27,646	$83.2K	0.00%
Point72 Asset Management, L.P.	23,538	$70.8K	0.00%
Jump Financial, LLC	16,800	$50.6K	0.00%
Prime Capital Investment Advisors, LLC	15,915	$47.9K	0.00%
Grange Capital, LLC	14,725	$44.3K	0.04%
Gsa Capital Partners LLP	11,476	$35.0K	0.00%
Carmel Capital Partners, LLC	10,000	$30.1K	0.01%
Jones Financial Companies LLLP	1,000	$2.87K	0.00%

Sold out (10)

Institutions that held GENELUX Corp at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of GNLX in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Susquehanna International Group, LLP	61,980	$150.0K
683 Capital Management, LLC	60,000	$145.2K
Catalyst Funds Management Pty Ltd	21,824	$52.8K
Omers Administration Corp	17,600	$42.6K
Nine Masts Capital Ltd	17,473	$42.3K
Diametric Capital, LP	12,150	$29.4K
MAI Capital Management	11,757	$28.5K
Centaurus Financial, Inc.	10,000	$24.0K
Cassaday & Co Wealth Management LLC	2,553	$6.18K
Simplex Trading, LLC	106	$256